九典制药(300705) - 300705九典制药投资者关系管理信息20250103

Group 1: Sales Performance - The sales volume of Loxoprofen Sodium Gel Patches has shown significant growth, with a positive operational trend [2] - The market size for external patch agents in 2023 is approximately ¥203.64 billion, with hospitals accounting for 69.89% and retail for 30.11% [2] Group 2: Pricing and Cost Reduction - The winning bid price for Loxoprofen Sodium Gel Patches in the Guangdong Alliance and "3+N" regions is ¥18.19 per patch, with a price reduction of about 25% [3] - In Zhejiang and Yunnan provinces, the winning bid price is ¥17.37 per patch, with a price reduction of approximately 28% [3] Group 3: Future Product Development - The company plans to enhance its sales strategy by increasing resources for the external market and building the "JiuYue" brand [3] - Expected approvals for new patch products include Indomethacin Gel Patch and Flurbiprofen Gel Patch in 2025, and Loxoprofen Sodium Patch and Ketoprofen Patch in 2026 [3] Group 4: Corporate Strategy and Governance - The company aims to expand sales channels, particularly in the external market, while enhancing brand influence [4] - There are plans to implement an employee stock incentive program to align employee interests with company growth [3] - The company is focused on increasing R&D efforts and optimizing production processes to ensure efficient operations and good returns for shareholders [4]